BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinto MP, Dye WW, Jacobsen BM, Horwitz KB. Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling. BMC Cancer 2014;14:735. [PMID: 25274034 DOI: 10.1186/1471-2407-14-735] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Majid Rasheed H, Farooq U, Bashir K, Wahid F, Khan T, Khusro A, Gajdács M, Alghamdi S, Amer Alsaiari A, Almehmadi M, Afzal S, Umar Khayam Sahibzada M. Isolation of oleanolic acid from Lavandula stoechas and its potent anticancer properties against MCF-7 cancer cells via induced apoptosis. Journal of King Saud University - Science 2022. [DOI: 10.1016/j.jksus.2022.102454] [Reference Citation Analysis]
2 Uddin MN, Wang X. Identification of breast cancer subtypes based on gene expression profiles in breast cancer stroma. Clinical Breast Cancer 2022. [DOI: 10.1016/j.clbc.2022.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Özkan H, Öztürk DG, Korkmaz G. Transcriptional Factor Repertoire of Breast Cancer in 3D Cell Culture Models. Cancers 2022;14:1023. [DOI: 10.3390/cancers14041023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Van Petten de Vasconcelos Azevedo F, Lopes DS, Zóia MAP, Correia LIV, Saito N, Fonseca BB, Polloni L, Teixeira SC, Goulart LR, de Melo Rodrigues Ávila V. A New Approach to Inhibiting Triple-Negative Breast Cancer: In Vitro, Ex Vivo and In Vivo Antiangiogenic Effect of BthTx-II, a PLA2-Asp-49 from Bothrops jararacussu Venom. Biomolecules 2022;12:258. [DOI: 10.3390/biom12020258] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Foglietta F, Serpe L, Canaparo R. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems. Cells 2021;10:3295. [PMID: 34943803 DOI: 10.3390/cells10123295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Chou CW, Huang YM, Chang YJ, Huang CY, Hung CS. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer. Int J Med Sci 2021;18:2521-31. [PMID: 34104083 DOI: 10.7150/ijms.59177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bai F, Liu S, Liu X, Hollern DP, Scott A, Wang C, Zhang L, Fan C, Fu L, Perou CM, Zhu WG, Pei XH. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors. Breast Cancer Res 2021;23:10. [PMID: 33478572 DOI: 10.1186/s13058-021-01387-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nii T, Makino K, Tabata Y. Three-Dimensional Culture System of Cancer Cells Combined with Biomaterials for Drug Screening. Cancers (Basel) 2020;12:E2754. [PMID: 32987868 DOI: 10.3390/cancers12102754] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 39.5] [Reference Citation Analysis]
9 Raghavan S, Snyder CS, Wang A, McLean K, Zamarin D, Buckanovich RJ, Mehta G. Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling. Cancers (Basel) 2020;12:E2063. [PMID: 32726910 DOI: 10.3390/cancers12082063] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
10 Huang W, Liang Y, Chung HY, Wang G, Huang JJ, Li Y. Cyperenoic acid, a sesquiterpene derivative from Croton crassifolius, inhibits tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in breast cancer. Phytomedicine 2020;76:153253. [PMID: 32531699 DOI: 10.1016/j.phymed.2020.153253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Mendoza-Reinoso V, McCauley LK, Fournier PGJ. Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers (Basel) 2020;12:E1014. [PMID: 32326073 DOI: 10.3390/cancers12041014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
12 Luzo ACM, Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon 2020;6:e03660. [PMID: 32258495 DOI: 10.1016/j.heliyon.2020.e03660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Shi Q, Xu R, Song G, Lu H, Xue D, He X, Xia Y. GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism. Cancer Gene Ther 2020;27:726-38. [PMID: 31636361 DOI: 10.1038/s41417-019-0146-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao L, Niu H, Liu Y, Wang L, Zhang N, Zhang G, Liu R, Han M. LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells. J Cancer 2019;10:6481-90. [PMID: 31777578 DOI: 10.7150/jca.33223] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
15 Menezes GLG, Mann RM, Meeuwis C, Bisschops B, Veltman J, Lavin PT, van de Vijver MJ, Pijnappel RM. Optoacoustic imaging of the breast: correlation with histopathology and histopathologic biomarkers. Eur Radiol 2019;29:6728-40. [PMID: 31134367 DOI: 10.1007/s00330-019-06262-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
16 Houthuijzen JM, Jonkers J. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev 2018;37:577-97. [PMID: 30465162 DOI: 10.1007/s10555-018-9768-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 31.0] [Reference Citation Analysis]
17 Sae-Lim S, Soontornworajit B, Rotkrua P. Inhibition of Colorectal Cancer Cell Proliferation by Regulating Platelet-Derived Growth Factor B Signaling with a DNA Aptamer. Asian Pac J Cancer Prev 2019;20:487-94. [PMID: 30803211 DOI: 10.31557/APJCP.2019.20.2.487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Kim H, Shin JE, Koo HS, Kwon H, Choi DH, Kim JH. Effect of Autologous Platelet-Rich Plasma Treatment on Refractory Thin Endometrium During the Frozen Embryo Transfer Cycle: A Pilot Study. Front Endocrinol (Lausanne) 2019;10:61. [PMID: 30837945 DOI: 10.3389/fendo.2019.00061] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 17.0] [Reference Citation Analysis]
19 Hsu YL, Yen MC, Chang WA, Tsai PH, Pan YC, Liao SH, Kuo PL. CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB. Breast Cancer Res 2019;21:23. [PMID: 30755260 DOI: 10.1186/s13058-019-1114-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
20 Wang X, Li Y, Mou Y, Yue Z, Zhang H, Li R, Sun H. Ethanol Extract from Brucea Javanica Seed Inhibits Angiogenesis Mediated by Platelet Derived Growth Factor Receptor-beta. Int J Med Sci 2018;15:1517-21. [PMID: 30443173 DOI: 10.7150/ijms.28337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Jitariu AA, Raica M, Cîmpean AM, Suciu SC. The role of PDGF-B/PDGFR-BETA axis in the normal development and carcinogenesis of the breast. Crit Rev Oncol Hematol 2018;131:46-52. [PMID: 30293705 DOI: 10.1016/j.critrevonc.2018.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
22 Gattino F, Maniscalco L, Iussich S, Biasato I, Martano M, Morello E, Gola C, Millán Ruiz Y, Saeki N, Buracco P, Martín de las Mulas J, De Maria R. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines. Veterinary Record 2018;183:221-221. [DOI: 10.1136/vr.104414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Nilendu P, Sarode SC, Jahagirdar D, Tandon I, Patil S, Sarode GS, Pal JK, Sharma NK. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol (Dordr) 2018;41:353-67. [PMID: 30027403 DOI: 10.1007/s13402-018-0388-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
24 Fang X, Xie H, Luo M, Chen Z, Wang F, Li Q, Wang X, Ding J, Fu L. PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis. Biochemical Pharmacology 2018;150:131-40. [DOI: 10.1016/j.bcp.2018.01.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
25 Butti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer 2018;17:34. [PMID: 29455658 DOI: 10.1186/s12943-018-0797-x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 29.3] [Reference Citation Analysis]
26 Choi N, Moon J, Sung J. PDGF. Encyclopedia of Signaling Molecules 2018. [DOI: 10.1007/978-3-319-67199-4_101813] [Reference Citation Analysis]
27 Ham SL, Thakuri PS, Plaster M, Li J, Luker KE, Luker GD, Tavana H. Three-dimensional tumor model mimics stromal - breast cancer cells signaling. Oncotarget 2018;9:249-67. [PMID: 29416611 DOI: 10.18632/oncotarget.22922] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
28 Klinkhammer BM, Floege J, Boor P. PDGF in organ fibrosis. Mol Aspects Med 2018;62:44-62. [PMID: 29155002 DOI: 10.1016/j.mam.2017.11.008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 18.4] [Reference Citation Analysis]
29 Roberts S, Speirs V. Advances in the development of improved animal-free models for use in breast cancer biomedical research. Biophys Rev 2017;9:321-7. [PMID: 28748520 DOI: 10.1007/s12551-017-0276-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
30 Kast RE, Skuli N, Cos S, Karpel-Massler G, Shiozawa Y, Goshen R, Halatsch ME. The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy. Breast Cancer (Dove Med Press) 2017;9:495-514. [PMID: 28744157 DOI: 10.2147/BCTT.S139963] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
31 Ravi M, Ramesh A, Pattabhi A. Contributions of 3D Cell Cultures for Cancer Research. J Cell Physiol 2017;232:2679-97. [PMID: 27791270 DOI: 10.1002/jcp.25664] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
32 Cimpean AM, Cobec IM, Ceaușu RA, Popescu R, Tudor A, Raica M. Platelet Derived Growth Factor BB: A "Must-have" Therapeutic Target "Redivivus" in Ovarian Cancer. Cancer Genomics Proteomics 2016;13:511-7. [PMID: 27807074 DOI: 10.21873/cgp.20014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
33 Zhou Z, Yao H, Hu H. Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer. Adv Exp Med Biol 2017;1026:171-95. [PMID: 29282684 DOI: 10.1007/978-981-10-6020-5_8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
34 Pinto MP, Sotomayor P, Carrasco-Avino G, Corvalan AH, Owen GI. Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells. Int J Mol Sci 2016;17:E1489. [PMID: 27608016 DOI: 10.3390/ijms17091489] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
35 Aronowitz JA, Lockhart RA, Hakakian CS, Hicok KC. Clinical Safety of Stromal Vascular Fraction Separation at the Point of Care. Ann Plast Surg 2015;75:666-71. [PMID: 26207555 DOI: 10.1097/SAP.0000000000000594] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
36 Pradhan S, Hassani I, Clary JM, Lipke EA. Polymeric Biomaterials for In Vitro Cancer Tissue Engineering and Drug Testing Applications. Tissue Eng Part B Rev 2016;22:470-84. [PMID: 27302080 DOI: 10.1089/ten.TEB.2015.0567] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
37 Roberts GC, Morris PG, Moss MA, Maltby SL, Palmer CA, Nash CE, Smart E, Holliday DL, Speirs V. An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer. PLoS One 2016;11:e0157004. [PMID: 27300768 DOI: 10.1371/journal.pone.0157004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
38 Choi N, Moon J, Sung J. PDGF. Encyclopedia of Signaling Molecules 2016. [DOI: 10.1007/978-1-4614-6438-9_101813-1] [Reference Citation Analysis]
39 Gao H, Zhang Z. Systematic Analysis of Endometrial Cancer-Associated Hub Proteins Based on Text Mining. Biomed Res Int 2015;2015:615825. [PMID: 26366417 DOI: 10.1155/2015/615825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
40 Farooqi AA, Siddik ZH. Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape. Cell Biochem Funct 2015;33:257-65. [PMID: 26153649 DOI: 10.1002/cbf.3120] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 10.4] [Reference Citation Analysis]